Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cem Mat

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinics in Dermatology|April 29, 2014
Behçet's disease as a systemic diseaseM Cem Mat, Ayşegül Sevim, Izzet Fresko, et al.
International Journal of Dermatology|May 1, 1988
The HLA association of lepromatous leprosy and borderline lepromatous leprosy in Turkey. A preliminary studyM Cem Mat, H Yazici, F Ozbakir, et al.
The American Journal of Dermatopathology|July 19, 2013
Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literatureZekayi Kutlubay, Orkhan Bairamov, Aysegul Sevim, et al.
International Journal of Dermatology|May 17, 2006
The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective studyM Cem Mat, Nadir Goksugur, Burhan Engin, et al.
International Journal of Nanomedicine|April 5, 2016
Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluationsM Sedef Erdal, Gül Özhan, M Cem Mat, et al.
Journal of Thrombosis and Thrombolysis|February 12, 2011
Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathyMehmet Agirbasli, Mesut Eren, Fatih Eren, et al.
European Journal of Nuclear Medicine|December 31, 1998
Evaluation of renal function in low-dose cyclosporine-treated patients using technetium-99m diaminocyclohexane: a cationic tubular excretion agentK Sonmezoglu, T Y Erdil, M Demir, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinics in Dermatology|April 29, 2014
Behçet's disease as a systemic diseaseM Cem Mat, Ayşegül Sevim, Izzet Fresko, et al.
International Journal of Dermatology|May 1, 1988
The HLA association of lepromatous leprosy and borderline lepromatous leprosy in Turkey. A preliminary studyM Cem Mat, H Yazici, F Ozbakir, et al.
The American Journal of Dermatopathology|July 19, 2013
Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literatureZekayi Kutlubay, Orkhan Bairamov, Aysegul Sevim, et al.
International Journal of Dermatology|May 17, 2006
The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective studyM Cem Mat, Nadir Goksugur, Burhan Engin, et al.
International Journal of Nanomedicine|April 5, 2016
Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluationsM Sedef Erdal, Gül Özhan, M Cem Mat, et al.
Journal of Thrombosis and Thrombolysis|February 12, 2011
Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathyMehmet Agirbasli, Mesut Eren, Fatih Eren, et al.
European Journal of Nuclear Medicine|December 31, 1998
Evaluation of renal function in low-dose cyclosporine-treated patients using technetium-99m diaminocyclohexane: a cationic tubular excretion agentK Sonmezoglu, T Y Erdil, M Demir, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Pageof 1